Clinical Use of Hormones in Age Management Medicine - Module 2
COURSE COST – $399.00
Courses are Enduring Materials from a Clinical Applications for Age Management Medicine Conference
This course is the second in a series of lectures designed to provide clinicians with focused lectures on the topic of Clinical Hormone Use giving them information on hormone testing, general hormone issues and specifics of men’s and women’s HRT. This set of lectures is a prerequisite and considered the first part for the full day live session Advanced Hormone Workshop: Focus on Estrogen, Progesterone, Testosterone, Thyroid and DHEA which will be held in November 2020 in Dallas, Texas. Speakers will discuss optimization of hormone levels within the context of Age Management Medicine using providing the evidence in the form of cases, studies and references to support their materials.
Curriculum
A detailed look at the connection between estrogen, progesterone, and testosterone in both women and men in aging. A discussion and literature review of how these three hormones confer a sense of potency, power, and self esteem in both men and women. A discussion of how the Hypothalamic-Pituitary-Adrenal axis plays a role in the decline and maintenance of these three hormones. Case studies will be reviewed for emphasis.
Benjamin S. Gonzalez, M.D.
Medical Director, Atlantis Medical Wellness Center, Silver Spring, MD
Testosterone is given credit for building muscle mass and improving libido, but is often under discussed outside of these areas. Testosterone receptors on the brain and in the bone are critical for so much more in terms of optimal function in our system. Testosterone does have the potential to be naturally modulated, through botanicals and nutrients. We will review research that indicates which therapies are most effective. Testosterone also plays a role in enzymatic activity such as Cystathionine-β-synthase or CBS so is involved in methylation cycles and homocysteine control. Testosterone, while only a tenth of the level in women that it is in men, is still pivotal to well-being in women’s health. We will review some of the distinctions between testosterone activity in men and women, and where our focus should be for healthy testosterone management. Testosterone is
emerging as a key player in fertility and a role in breast cancer as well. We will examine these areas, and move through the research to find the evidence that best supports effective testosterone management in men and women.
Cheryl Burdette, ND
Director of Education and Residency, Progressive Medical Clinics
Consultant, Dunwoody Labs & LabCorp
With some 400 identified functions in the body, estrogen is perhaps the most studied compound in the history of humanity. As an introduction, Dr. Clearfield discusses estrogen in context of maintaining metabolic rate, improving insulin sensitivity, body temperature regulation, muscle maintenance, improved sleep, reduced incidence of cataracts, increased blood flow, decreased accumulation of arterial plaque, reducing visceral fat, memory enhancement, mood enhancement and preserving the amount of collagen in the skin, Estrogen replacement in the peri-and postmenopausal era, however, is not without controversy. The 2002 Women’s Health Initiative identified prescription estrogen as potentially inducing an increased incidence of breast cancer, blood clots, and strokes. This lecture discusses the physiology of estrogen, the indications and contraindications of estrogen as replacement therapy in the menopausal period, the safety of plant-based “natural” estrogens as opposed to equine based synthetic estrogen, the estrogen dominance syndrome, and the use of estrogen replacement therapy in the face of various hormonally related cancers. Lastly, we will review a case study, pointing out the intricacies of estrogen metabolism, its replacement in physiologic doses when indicated and clinical pearls gleamed from Dr. Clearfield’s twenty plus years of hormone replacement.
William Clearfield, D.O., FAAMA, DABMA, FAARFM
Medical Director, Clearfield Family Medicine, Reno, NV
By maintaining adequate, youthful, physiologic levels of testosterone, women enjoy increased energy, mood, mental clarity, sexual desire, and fulfillment, increased muscle and tissue strength. Despite thousands of peer-reviewed studies described in reputable medical journals, testosterone remains unapproved by the FDA for administration as a means of relieving the above lifestyle symptoms. This lecture discusses the physiology of testosterone in women, the rationale for prescribing “natural” plant-based testosterone to restore youthful hormonal levels including effects on brain and bone metabolism, sexual energy and sexual desire, mood, and memory versus commercially available synthetic compounds. No hormone is an island. We discuss the laboratory evaluation of testosterone and its derivative hormones, DHEA, dihydrotestosterone and estradiol and its relationship with the other hormones in the female hormonic symphony. We discuss treatment options including creams, injectables, and pellets. We will present a case study that includes a discussion of short and long-term benefits, side effects and contraindications of testosterone therapy in women.
William Clearfield, D.O., FAAMA, DABMA, FAARFM
Medical Director, Clearfield Family Medicine, Reno, NV
During the presentation, Dr. Strobel will present information to explain basic physiology of estrogen as well as the various ways in which estrogen is metabolized. The lecture will also explain estrogen’s effects on the various organs of the body as well as how choosing the form of delivery can impact overall health. This lecture is intended for the non-gynecologist and a beginner in hormone replacement therapy who would like to better understand estrogen.
G. DeAn Strobel, M.D., FACOG
Founder and President, G. DeAn Strobel, MD, PA, Sherman, TX
Founder and President, Allure Laser & Medical Spa, Sherman, TX
Teaching Faculty, Medical Advisory Board, and Mentor, BioTE Medical, Irving, TX
Hormone Replacement therapy (HRT) in women has had its ups and downs over the past 35 years. Observational studies in the 1980s and 1990s have shown a reduction in cardiovascular disease (CAD) in postmenopausal women using HRT. The Women’s Health Initiative (WHI) study in 1991 showed an increased risk of CAD while the estrogen only arm of that trial in 2002 showed no effect on CAD. The North American Menopause Society and the international menopause societies all do not recommend use of HRT to decrease CAD. The Kronos Early Estrogen Prevention Study (KEEPS) trial in 2012 from Harvard Medical School showed favorable effects of HRT in newly menopausal women. Other studies performed at the Mayo Clinic showed that HRT might have a role in preventing CAD. The current lecture will review some of the more recent published studies from peer reviewed medical journals. Topics will focus on how HRT is associated with a marked improvement in survival in postmenopausal women with advanced HF; how HRT significantly increases apolipoprotein A-I levels and decreases Lp(a) and the effects on serum markers of inflammation in women with CAD; and how HRT protects against smoking-induced changes in vascular structure and function. Results of a recent study presented at this year’s American College of Cardiology’s 66th Annual Scientific Sessions that showed lower atherosclerosis and very clear survival benefits in women using hormone replacement therapy will also be discussed. New Biomarkers to evaluate vulnerable plaques in women to see if they are candidates for HRT will also be addressed.
George Shapiro, M.D.
Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
President, Cenegenics, New York City
Member, AMMG Conference Planning Committee
Estradiol is a pleiotropic hormone that has instrumental influence over numerous critical functions related to the cardiac and vascular system, bone and mineral metabolism, cognition, memory, mood, balance, age related neurodegenerative disorders and lipolysis of fat. Evidence suggests that estradiol has neurotrophic and neuroprotective properties and promotes the survival and viability of intimate brain structures. The benefits of estradiol on neuroprotection are attributed to genomic and non-genomic signaling, regulation of mitochondrial energy and antioxidant action. Damaged neurons increase the production of aromatase, the enzyme that is responsible for the conversion of androgens into estradiol. Our own astrocytes after suffering trauma increase aromatase expression to exert the numerous benefits of estrogen to these intimate structures. Knowing all this to be an evident truth, why then do some clinicians insist on blocking the aromatization of testosterone into the ever-important, pleiotropic hormone estradiol? Attendees will learn the importance of allowing the natural aromatization of testosterone into estradiol to occur and how blocking this important conversion will do long term harm to these numerous systems.
Rob Kominiarek, D.O., FACOFP
Member, AMMG Planning Committee
Director, ReNue Health, Springboro, OH
Assistant Clinical Professor, Ohio University College of Osteopathic Medicine
The primary reason for low testosterone in younger aging males, and for some older aging males as well, is low gonadotrophin output, particularly LH. Leydig cells decline with aging and persistently low gonadotrophins and some diseases, i.e., hemochromatosis, hypothyroidism, etc. If boosting methods fail, then primary hypogonadism is present and replacement modalities are required. Reasons for low gonadotrophins today may be related to xeno-estrogens in diet and environmental intake. Additionally, obesity with increased endogenous estrogens, drugs and poor health or co-morbid diseases add to the long list that requires investigation. In this regard, we can do much to change negative patterns, but along with these changes we can add great benefits through boosting testosterone through increasing gonadotrophins or giving them directly. In my experience, boosting should be the first diagnostic and treatment intervention before direct replacement of testosterone is initiated, particularly under the age of 65. The three most common methods are: (1) Through the use of SERMS, such as clomiphene or analogues; (2) Suppression of endogenous conversion of androgens into estrogens within the hypothalamus with reversible aromatase inhibitors like anastrozole or femara; and (3) hCG – Chorionic Gonadotrophin, a direct LH containing natural compound with a very long history of safe, effective uses. My discussion will cover the background literature and my long use of all three modalities and some observations on potential problems and benefits of these approaches. Some of the unique benefits are poorly known and, sadly, under-utilized. Questions and answers will be welcomed depending on time constraints.
Eugene Shippen, M.D.
Medical Consultant for Lead Toxicology, Exide Technologies, Inc
This lecture will, in only one hour, demonstrate how to diagnose, and treat, male hypogonadism: subjective complaints, laboratory analysis, treatment modalities, and the general strategy for managing this insidious condition. Included will be the new low dose clomiphene therapy, HCG use in hypogonadism, managing estrogen, and the concept of “Backfilling the Pathways”, to optimize health and happiness in your adult male patients.
John K. Crisler, D.O.
President, Founder & CMO, All Things Male Center for Men’s Health, Lansing, MI
Consulting Physician, Defy Medical Centers
Dept. of Family and Community Medicine, Michigan State University-College of Osteopathic Medicine, East Lansing, MI
Content Note: Crisler advocated for aromatase inhibitors in small doses and only prescribed until the symptoms were resolved. This may be in conflict with other presentations and other opinions, however this was his view based in evidence.
It is estimated that one out of four men over 30 years old has low testosterone. Having low testosterone in men is considered a lethal disease with a higher incidence of heart disease, stroke and cancer. The number of prescriptions for testosterone is climbing rapidly. The use of exogenous testosterone is an option however one should always consider using a treatment that can help with boosting their natural production of testosterone. A review of using DHEA, Clomid, Enclomiphene, HCG, SARM and some new peptides will be discussed.
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Content Note: The compound LGD4033 mentioned in this presentation is not currently approved by the FDA.
FACULTY
- Medical Director, Atlantis Medical Wellness Center, Silver Spring, MD
Dr.González is an Integrative and Functional Health Provider professionally born out of the necessity to optimize patient care. He earned his M.D. from the University of Arizona College of Medicine and practiced as one of our U.S. Military’s leading emergency medicine and trauma physicians. He taught medicine at Walter Reed Army Medical Center and Penn State Hershey Medical Center and served as chief of the largest emergency and trauma service in the Iraq War. After recognizing the need for an emphasis in disease prevention rather than waiting for disease to occur, he founded the Atlantis Medical Wellness Center where he has developed and honed an integrative medical practice based on optimizing an individual’s health. As a Black Belt in Karate, Tae Kwon Do, and Kung Fu, a concert violinist, pilot, linguist, and teacher of these skills he is not only a true “Renaissance Man,” but Dr. González is a “Renaissance Man’s” doctor skilled in treating a wide range of medical conditions. He emphasizes an overall optimal and functional approach to an individual’s health at any age. Catching disease before it happens is his mantra. Dr. González teaches other health care providers the skills to integrate both evidence based medicine and experience based medicine.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Director of Education and Residency, Progressive Medical Clinics
- Consultant, Dunwoody Labs & LabCorp
Cheryl Burdette, N.D. is the Director of Education and the Naturopathic Residency program at Progressive Medical. She has been in private practice since 2001. She directs an accredited Naturopathic residency program that is focused on Integrative Medicine and Nutritional Biochemistry. She is the founder and Educational Director of a functional laboratory, Dunwoody Labs,for which she designs clinical profiles and trains clinicians in their utilization. At Dunwoody labs, she is involved in nutritional trials and translational research. She is the Research and Outreach director for Xymogen, an Inc.500 supplement company, and serves on their BOA. She also serves on an independent IRB giving feedback concerning various studies in integrated medicine. She lectures internationally and nationally for groups such as IFM, A4M, MMI, and ACAM. She wrote and designed the curriculum forAdvanced Medicine’s Academy online certification program in IntegrativeMedicine. She is called upon yearly todo grand rounds at all the major naturopathic medical schools. She has taughtClinical and Nutritional Oncology at the University of Bridgeport and is part of the faculty at the University of Miami, the first allopathic school to require Integrative Medicine training for MDs. She is also adjunct faculty at George Washington University, the first PhD program in Integrative Medicine.
FACULTY DISCLOSURE: Consultant for Dunwoody and Xymogen
- Medical Director, Clearfield Family Medicine, Reno, NV
Dr. William Clearfield, a graduate of LaSalle College, completed his medical training at the College of Osteopathic Medicine and Surgery, now Des Moines University in Des Moines, IA. He completed a rotating internship and served as an OB/GYN resident at Metropolitan Hospital, Philadelphia, PA and a Family Practice resident in 1982 at United Health and Hospital Services in Kingston, PA. He was certified by the American Board of Family Medicine and opened a private practice devoted to family and integrative medicine. Dr. Clearfield obtained a certificate degree in Cardiac Rehabilitation from the University of Wisconsin/Lacrosse and implemented a supervised diet and exercise program for cardiac patients at Nesbitt Hospital in Kingston, PA. Dr. Clearfield graduated from UCLA’s “Acupuncture for Physicians” program, served as Secretary of the American Academy of Medical Acupuncture, and was editor of the journal “Medical Acupuncture” from 1994 through 1996. In 1994, Dr. Clearfield established the first combined conventional and alternative medicine pain clinic at John Heinz Rehabilitation Hospital in Wilkes-Barre, PA. In 2002 Dr. Clearfield attended a workshop with instruction on testosterone hormone replacement implants and neuromodulators for facial rejuvenation, and his career took a different direction. Dr. Clearfield studied the intricacies and subtleties of anti-aging and wellness and safe hormone replacement therapy. He became a leading authority with many speaking engagements and publications throughout the United States. Also, Dr. Clearfield trained and in turn became an instructor in neuromodulator, dermal filler, laser therapies, the PDO Thread Lift, and Platelet Rich Plasma techniques, including facial, joint, genitourinary rejuvenation and is certified as a “Vampire” technique practitioner. Dr. Clearfield is one of three Nevada Delegates to the American Osteopathic Association’s House of Delegates and the Executive Director of the American Osteopathic Society of Rheumatic Diseases. He lectures extensively for A4M, the Nevada Osteopathic Medical Association, the Age Management Medicine Group, and along with Dr. Pamela Smith, presented a breakthrough six-hour mini-course on Bioidentical Hormone Therapy in 2017 at OMED, the American Osteopathic Association’s scientific conference in Philadelphia. So successful was this course, Dr. Clearfield expanded the curriculum to eight hours at OMED in San Diego, CA in October 2018.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Founder and President, G. DeAn Strobel, MD, PA, Sherman, TX
- Founder and President, Allure Laser & Medical Spa, Sherman, TX
- Teaching Faculty, Medical Advisory Board, and Mentor, BioTE Medical, Irving, TX
Dr. DeAn Strobel is a board-certified OB/GYN in private practice north of Dallas, TX, in the city of Sherman. She first completed a Bachelor of Science degree in mathematics and Spanish and attended graduate school in engineering before deciding that biological sciences and medicine were where she truly belonged. She is a graduate of Louisiana State University Medical Center and completed a residency in obstetrics and gynecology at Baylor University Medical Center in Dallas, TX in 1999.
Although initially attracted to surgery, she soon found a new interest in obstetrics and gynecology. Dr. Strobel enjoyed the combination of basic medicine, specialty studies, and surgery. Dr. Strobel began her practice in Sherman in 1999. After the birth of her twin boys in 2001, she then decided not to continue practicing obstetrics. She opened Allure Laser & Medical Spa in 2002.
After being in practice for only a short time, Dr. Strobel realized that there were many issues for which traditional medicine and training had not prepared her. This led her eventually to bioidentical hormones as well as functional medicine. Dr. Strobel incorporates bioidentical hormone therapy with traditional Western medicine, functional medicine, supplements and dietary therapy into her practice. She has over 18 years’ experience in various forms of bioidentical hormone replacement as well as gynecology and general practice.
FACULTY DISCLOSURE: Teaching, speaking honoraria, Advisory Board, BioTE
- Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
- President, Cenegenics, New York City
- Member, AMMG Conference Planning Committee
Dr. Shapiro has been a practicing physician for 30 years, specializing in Internal Medicine, Cardiovascular Disease and Age Management Medicine. His career in medicine began in 1988 when he graduated from New York Medical College. An internship and residency then followed at Albert Einstein College of Medicine, after which Dr. Shapiro completed a fellowship at Columbia University College of Physicians and Surgeons in 1994, focusing on Cardiovascular Disease Management, including Congestive Heart Failure and Heart Transplantation. Dr. Shapiro was the recipient of the 10th Annual Alan P. Mintz, M.D. Award for Clinical Excellence in Age Management Medicine, as he has become known nationwide as an expert in age management medicine, and leads one of the most prominent age management practices in the country as president of Cenegenics New York City. Always challenged by the need for innovative medicine, Dr. Shapiro has patented medical devices as well as explored and innovated new medical protocols. He has long been known as one of New York’s foremost cardiologists, specializing in regenerative medicine and improving longevity, including the genomics of cardiovascular disease and congestive heart failure. Affiliated with New York Presbyterian Hospital and an Adjunct Assistant Clinical Professor in Clinical Medicine at New York Medical College, Dr. Shapiro is active in 13 medical societies, has been a speaker for the Age Management Medicine Group (AMMG) group for many years, and is a long-standing member of the AMMG Conference Planning Committee. Dr. Shapiro was named a 2017 Top Doctor in New York City.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Member, AMMG Planning Committee
- Director, ReNue Health, Springboro, OH
- Assistant Clinical Professor, Ohio University College of Osteopathic Medicine
Dr. Rob Kominiarek is a board certified Fellow of the American College of Osteopathic Family Physicians and a Fellows Crest Award Winner with advanced training in Age Management Medicine and Hormone Optimization. He is president and medical director of ReNue Health®. Dr. Rob is a graduate of the Nova-Southeastern University, College of Osteopathic Medicine in Fort Lauderdale, Florida. He completed his residency training at Ohio University, Grandview Hospital and Medical Center in Dayton, Ohio and is an Assistant Clinical Professor at Ohio University. An Amazon Bestselling Author and Executive Producer of “Dr. Rob In the House” on NBC2 in Dayton, Ohio. Dr. Rob is a veteran of the United States Army and is a bestselling author with a passion directed towards overall health of the mind and body thru proper nutritional habits, regular exercise, appropriate supplementation, and the intelligent optimization of hormones.
Dr. Rob is an avid pilot currently flying a Cirrus SR22 and a Diamond DA-42 who enjoys cycling, swimming, triathlons, soccer, tennis, soaring, skiing Utah, Italian motorcycles, and automobile racing. Dr. Rob is a dedicated father who believes in practicing what he preaches, and as such lives a lifestyle dedicated towards healthy living and regular exercise.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Medical Consultant for Lead Toxicology, Exide Technologies, Inc
Dr. Shippen has been in medical practice since 1973. Primarily in Family Practice for the first 25 years and Endocrinology focused on male and female hormonal problems due to aging and disease until the present. After publication of the book, “The Testosterone Syndrome” in 1998, the focus of his practice changed to aging Endocrinology with an emphasis on male and female hormonal evaluation and treatment. This lead to many opportunities to lecture and provide tutorial seminars on these subjects both nationally and internationally.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- President, Founder & CMO, All Things Male Center for Men’s Health, Lansing, MI
- Consulting Physician, Defy Medical Centers
- Dept. of Family and Community Medicine, Michigan State University-College of Osteopathic Medicine, East Lansing, MI
“Dr. John” Crisler is an Osteopathic Physician located in Lansing, MI. Dr. Crisler got his start in hormone modulation and recovery therapies protecting professional and non-professional athletes from the adverse affects of anabolic steroid use. He has distinguished himself in the field of Age Management Medicine by developing new treatment protocols for Testosterone, and Thyroid optimization, which have influenced the way physicians all over the world treat their patients. His patients also derive the benefits of his substantial experience in treating Adrenal Fatigue, and is one of few physicians who address the dreaded Post Finasteride Syndrome (PFS). Commanding a substantial Internet following, Dr. Crisler founded the first Internet Forum on TRT moderated by a physician, and has answered more medical questions pro bono than any doctor in the history of the Internet. Dr. Crisler is a strong advocate for TRT, which he describes as “the most significant advancement in men’s health in history.” His ethical standards led to a feature article in Playboy magazine in April 2007, called “Dr T to the Rescue” (“Dr T” standing for testosterone, is Dr. John’s nickname). Dr. Crisler has proudly become a mainstay at medical conferences in our field, for whom he has lectured, co-hosted and moderated across the country and around the world. His paper, “Testosterone Replacement Therapy: A Recipe for Success” after becoming the most highly read in the history of the field of Endocrinology, has now been expanded into a very popular book. Dr. John enjoys training fellow physicians, as well as the public, and is known as an informative, dynamic and highly entertaining speaker.
FACULTY DISCLOSURE: No Relevant Relationships with a Commercial Interest to Disclose
- Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
- Founder, Institute for Hormonal Balance, Orlando, FL
- Member, AMMG Conference Planning Committee
Dr. Edwin Lee is an endocrinologist, author and international speaker. Dr. Lee founded the Institute for Hormonal Balance, Orlando, FL in 2008, is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism, and has completed special training in Regenerative and Functional Medicine. Currently, he is the assistant professor of Internal Medicine at the University of Central Florida College of Medicine. In addition to writing his award winning books, “Your Amazing Heart,” “Your Awesome Brain,” “Feel Good Look Younger: Reversing Tiredness Through Hormonal Balance,” and “Your Best Investment: Secrets to a Healthy Body and Mind,” Dr. Lee has published many articles on internal medicine and endocrinology. He was also an author in the fourth edition of Textbook of Critical Care. His passion is healthy living and he practices what he preaches. He enjoys participating in open water swimming, cycling, hiking and Aquabike competition. Dr. Edwin Lee resides in Orlando, FL with his wife and 2 teenage boys.
FACULTY DISCLOSURE: Speaker with honorarium, Tailor Made Compounding
Course Information
Faculty / Planner Disclosures of Conflict of Interest
Conference Planning Committee
Mary L. Corry, R.N. – No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Edwin Lee, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
No member of The Foundation for Care Management or the Age Management Medicine Group has any relevant financial relationships to disclose in regards to this activity.
Faculty
Cheryl Burdette N.D. – Consultant for Dunwoody and Xymogen
William Clearfield, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
John K. Crisler D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Benjamin Gonzalez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob Kominiarek D.O., FACOFP – No Relevant Relationships with a Commercial Interest to Disclose
Edwin N. Lee M.D., FACE – Speaker with honorarium, Tailor Made Compounding
George Shapiro M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Eugene Shippen M.D. – No Relevant Relationships with a Commercial Interest to Disclose
G DeAn Strobel M.D., FACOG – Teaching, speaking honoraria, Advisory Board, BioTE
Acknowledgement of Financial Commercial Support
No in-kind financial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Learning Objectives:
- Summarize the legal medical use of Estrogen, Progesterone, and Testosterone in its medical use.
- Discuss essential scientific information for the use of Estrogen, Progesterone, and Testosterone in patients with diagnosed deficiencies and explain how to clinically apply this knowledge in your practice to improve patient outcomes.
- Discuss essential scientific information for the use of Estrogen, Progesterone, and Testosterone in patients in other areas of medical use such as unique female issues, male issues and sexual dysfunction and explain how to clinically apply this knowledge in your practice to improve patient outcomes.
- Summarize indications and contraindications for the use of Estrogen, Progesterone, and Testosterone.